Pharscin Pharmaceutical Renews Manufacturing License

MT Newswires Live2025-11-19

Chongqing Pharscin Pharmaceutical (SHE:002907) renewed its drug manufacturing license and received a renewed license from the Chongqing Medical Products Administration, according to a Shenzhen bourse filing on Wednesday.

The amendment included the extension of Youhua Pharmaceutical Technology's commissioned manufacturing period of montelukast sodium granules to March 2, 2026.

The drug is used for the prevention and treatment of asthma in children 1 years old and older, as well as treating allergic rhinitis in children aged 2 to 5 years old.

The renewed license is valid until June 29, 2030.

The Chinese pharmaceutical company's shares slipped over 1% during the morning trade.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2584999907?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-19 11:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2584999907","market":"sg","top_or_hot":-1,"title":"Pharscin Pharmaceutical Renews Manufacturing License","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/002907\">Chongqing Pharscin</a> Pharmaceutical (SHE:002907) renewed its drug manufacturing license and received a renewed license from the Chongqing Medical Products Administration, according to a Shenzhen bourse filing on Wednesday.</p><p>The amendment included the extension of Youhua Pharmaceutical Technology's commissioned manufacturing period of montelukast sodium granules to March 2, 2026.</p><p>The drug is used for the prevention and treatment of asthma in children 1 years old and older, as well as treating allergic rhinitis in children aged 2 to 5 years old.</p><p>The renewed license is valid until June 29, 2030.</p><p>The Chinese pharmaceutical company's shares slipped over 1% during the morning trade.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pharscin Pharmaceutical Renews Manufacturing License</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPharscin Pharmaceutical Renews Manufacturing License\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-11-19 11:20</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/002907\">Chongqing Pharscin</a> Pharmaceutical (SHE:002907) renewed its drug manufacturing license and received a renewed license from the Chongqing Medical Products Administration, according to a Shenzhen bourse filing on Wednesday.</p><p>The amendment included the extension of Youhua Pharmaceutical Technology's commissioned manufacturing period of montelukast sodium granules to March 2, 2026.</p><p>The drug is used for the prevention and treatment of asthma in children 1 years old and older, as well as treating allergic rhinitis in children aged 2 to 5 years old.</p><p>The renewed license is valid until June 29, 2030.</p><p>The Chinese pharmaceutical company's shares slipped over 1% during the morning trade.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"002907","symbol_name":"华森制药","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2584999907","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2584999907","pubTimestamp":1763522410,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Chongqing Pharscin Pharmaceutical  renewed its drug manufacturing license and received a renewed license from the Chongqing Medical Products Administration, according to a Shenzhen bourse filing on Wednesday.The amendment included the extension of Youhua Pharmaceutical Technology's commissioned manufacturing period of montelukast sodium granules to March 2, 2026.The drug is used for the prevention and treatment of asthma in children 1 years old and older, as well as treating allergic rhinitis in children aged 2 to 5 years old.The renewed license is valid until June 29, 2030.The Chinese pharmaceutical company's shares slipped over 1% during the morning trade.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"002907":"华森制药","BK0239":"医药制造"},"translate_title":"Pharscin Pharmaceutical更新生产许可证","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"002907":0.9},"content_text":"Chongqing Pharscin Pharmaceutical (SHE:002907) renewed its drug manufacturing license and received a renewed license from the Chongqing Medical Products Administration, according to a Shenzhen bourse filing on Wednesday.The amendment included the extension of Youhua Pharmaceutical Technology's commissioned manufacturing period of montelukast sodium granules to March 2, 2026.The drug is used for the prevention and treatment of asthma in children 1 years old and older, as well as treating allergic rhinitis in children aged 2 to 5 years old.The renewed license is valid until June 29, 2030.The Chinese pharmaceutical company's shares slipped over 1% during the morning trade.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2584999907","isCrawlerRequest":true}